Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial.

Journal:
Circulation
Published:
DOI:
10.1161/circulationaha.125.075080
Affiliations:
21
Authors:
21
Institutions Authors Share
Abbott, United States of America (USA)
4.000000
0.19
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)
2.000000
0.10
Osaka Keisatsu Hospital, Japan
1.000000
0.05
Charlton Memorial Hospital, United States of America (USA)
1.000000
0.05
Advanced Heart And Vein Center, United States of America (USA)
1.000000
0.05
Changi General Hospital, Singapore
1.000000
0.05
University of Colorado Anschutz Medical Campus (CU Anschutz), United States of America (USA)
1.000000
0.05
NewYork-Presbyterian / Weill Cornell Medical Center, United States of America (USA)
1.000000
0.05
University Hospitals Cleveland Medical Center, CWRU, United States of America (USA)
1.000000
0.05
National Taiwan University Hospital (NTUH), Taiwan
1.000000
0.05
Mount Sinai Hospital, ISMMS, United States of America (USA)
1.000000
0.05
Hackensack University Medical Center (Hackensack UMC), United States of America (USA)
1.000000
0.05
Ballad Health, United States of America (USA)
1.000000
0.05
St. Francis Hospital, United States of America (USA)
1.000000
0.05
Syntropic CoreLab, United States of America (USA)
0.500000
0.02
OhioHealth, United States of America (USA)
0.500000
0.02
Prince of Wales Hospital, Australia
0.500000
0.02
University of New South Wales (UNSW Sydney), Australia
0.500000
0.02
The University of Auckland, New Zealand
0.500000
0.02
Auckland City Hospital (ACH), New Zealand
0.500000
0.02